P. Velásquez-Mieyer

发表

Longitudinal study of muscle strength, quality, and adipose tissue infiltration.

T. Manini, A. Newman, M. Visser, 2009, The American journal of clinical nutrition.

Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects

G. Umpierrez, A. Cashion, R. Lustig, 2003, International Journal of Obesity.

Lifestyle Medicine in Diabetes Care: The Lifedoc Health Model

R. Nieto-Martínez, J. Mechanick, J. González-Rivas, 2022, American journal of lifestyle medicine.

Type 2 diabetes mellitus in children and adolescents: the new challenge.

G. Burghen, P. Velásquez-Mieyer, M. Christensen, 2004, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Factors Affecting Hemoglobin A1C in the Diagnosis of Diabetes and Prediabetes in Youth.

P. Velásquez-Mieyer, P. Cowan, C. Neira, 2016, Journal of pediatric nursing.

Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults

K. Arheart, R. Lustig, P. Velásquez-Mieyer, 2003, International Journal of Obesity.

Obesity, leptin resistance, and the effects of insulin reduction

J. Soberman, R. Lustig, P. Velásquez-Mieyer, 2004, International Journal of Obesity.

Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults

G. Umpierrez, M. Christensen, A. Cashion, 2004, International Journal of Obesity.

Perceived barriers and facilitators to physical activity in kidney transplant recipients.

A. Cashion, P. Velásquez-Mieyer, M. Wicks, 2007, Progress in transplantation.

Impact of a Multidisciplinary Approach on Cardiometabolic Risk Reduction in a Multiracial Cohort of Adults: A 1-Year Pilot Study

R. Nieto-Martínez, J. Mechanick, Xichen Mou, 2022, Nutrients.

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus

P. Velásquez-Mieyer, C. Neira, Claudia P. Neira, 2008 .

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

Single‐ and Multiple‐Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes

W. Tamborlane, B. Meibohm, E. Capparelli, 2005, Journal of clinical pharmacology.

Review: Obesity and cardiometabolic syndrome in children

P. Velásquez-Mieyer, P. Cowan, C. Neira, 2007, Therapeutic advances in cardiovascular disease.

Therapeutic Advances in Cardiovascular Disease

P. Velásquez-Mieyer, P. Cowan, C. Neira, 2007 .

Current and Future Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents

P. Velásquez-Mieyer, M. Christensen, Johanna T. Mallare, 2005 .

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

M. Hudson, Hao Li, R. Lustig, 1999, The Journal of pediatrics.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

F. Greenway, D. Heimburger, G. Warsi, 2006, International Journal of Obesity.

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.

P. Bacchetti, R. Lustig, P. Velásquez-Mieyer, 2006, The Journal of pediatrics.

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

M. Wheeler, N. Dixit, W. Tamborlane, 2023, The Lancet Diabetes & Endocrinology.

Calcium Intake and Body Composition in African-American Children and Adolescents at Risk for Overweight and Obesity

F. Tylavsky, P. Velásquez-Mieyer, P. Cowan, 2010, Nutrients.

Identifying Children at Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease

P. Velásquez-Mieyer, P. Cowan, Sylvia Pérez-Faustinelli, 2005 .

The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting

P. Velásquez-Mieyer, P. Cowan, C. Neira, 2009, Journal of the American Academy of Nurse Practitioners.

Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents.

P. Velásquez-Mieyer, G. Wetzel, P. Cowan, 2011, Journal of pediatric nursing.

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents

P. Velásquez-Mieyer, P. Cowan, K. Harden, 2007, Journal of the American Academy of Nurse Practitioners.

Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting

F. Tylavsky, P. Velásquez-Mieyer, P. Cowan, 2008, The journal of nutrition, health & aging.

A pilot study of QT interval analysis in overweight and obese youth.

P. Velásquez-Mieyer, P. Cowan, Shirleatha T. Lee, 2011, Applied nursing research : ANR.

Perceived Barriers and Facilitators to Physical Activity in Kidney Transplant Recipients

A. Cashion, P. Velásquez-Mieyer, M. Wicks, 2007, Progress in transplantation.

Relative Body Mass Index Improves the BMI Percentile Performance for Detection and Monitoring of Excess Adiposity in Adolescents

R. Nieto-Martínez, P. Velásquez-Mieyer, E. Ugel, 2024, Nutrients.